Hepatocellular carcinoma (HCC) is one of most prevalent cancer and is a serious healthcare
issue worldwide. Portal vein tumor thrombus (PVTT) is a frequent complication and remains …

Background In addition to their pivotal roles in coagulation and thrombosis, platelets are
crucial in tumor progression, with plenty of clinical and experimental data demonstrating that …

Background and Aims Immunotherapy with PD-1 inhibitors combined with tyrosine kinase
inhibitors (TKIs) has been proven to be effective against advanced hepatocellular carcinoma …

Purpose: This study aimed to evaluate the efficacy and safety of camrelizumab plus apatinib
with or without stereotactic body radiotherapy (SBRT) as first-line therapy for patients with …

Hepatocellular carcinoma is the fourth leading cause of cancer-related deaths globally.
Advanced nanomaterials have emerged as effective approaches to liver cancer therapy …

Background Hepatocellular carcinoma (HCC) is one of the main reasons for malignancy-
related death. Portal vein tumor thrombosis (PVTT) is the most common form of …

Background This study aimed to evaluate the efficiency and prognostic factors of lenvatinib
plus programmed death 1 (PD-1) blockades in patients with advanced hepatocellular …

Abstract Background and Aim The prognosis of hepatocellular carcinoma (HCC) with portal
vein tumor thrombosis (PVTT) is very poor. This study aimed to evaluate hepatic arterial …

Simple Summary The survival of patients with hepatocellular carcinoma (HCC) is highly
variables, due to heterogeneous tumor burden and liver dysfunction. Tumor burden score …

Aberrant lipid metabolism is an essential feature of hepatocellular carcinoma (HCC). Fatty
acid transport protein-5 (FATP5) is highly expressed in the liver and is involved in the fatty …